(Q34740561)

4 August 2017

title

Efficacy and toxicity of a protocol using sirolimus, tacrolimus and daclizumab in a nonhuman primate renal allotransplant model (English)

1 reference

4 August 2017

1 reference

Sean P Montgomery

1

1 reference

4 August 2017

Steven R Mog

2

1 reference

4 August 2017

He Xu

3

1 reference

4 August 2017

Douglas K Tadaki

4

1 reference

4 August 2017

Boaz Hirshberg

5

1 reference

4 August 2017

Justin D Berning

6

1 reference

4 August 2017

John Leconte

7

1 reference

4 August 2017

David M Harlan

8

1 reference

4 August 2017

Douglas Hale

9

1 reference

4 August 2017

Allan D Kirk

10

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

American Journal of Transplantation

4 August 2017

published in

1 reference

4 August 2017

volume

2

1 reference

4 August 2017

issue

4

1 reference

4 August 2017

page(s)

381-385

1 reference

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20415.X

CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20415.X

Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20415.X

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20415.X

The Banff 97 working classification of renal allograft pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20415.X

Tacrolimus (FK506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20415.X

7 January 2021

Effect of tacrolimus (FK506) and sirolimus (rapamycin) mono- and combination therapy in prolongation of renal allograft survival in the monkey

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20415.X

7 January 2021

High-resolution HLA-DRB typing using denaturing gradient gel electrophoresis and direct sequencing

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20415.X

7 January 2021

Rapamycin for immunosuppression in organ allografting.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20415.X

7 January 2021

Effects of rapamycin in experimental organ allografting

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20415.X

7 January 2021

Sirolimus (rapamycin) halts and reverses progression of allograft vascular disease in non-human primates

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20415.X

7 January 2021

10.1034/J.1600-6143.2002.20415.X

Identifiers

DOI

1 reference

4 August 2017

1 reference